Mobilization policy in multiple myeloma: minimum target or law of redundancy? Two different approaches by the two sides of the Atlantic Ocean.

about

Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score.

P2860

Q48251589-AF6C35F9-4BBE-498E-8AAA-7B25EE3A797B

P2860

Mobilization policy in multiple myeloma: minimum target or law of redundancy? Two different approaches by the two sides of the Atlantic Ocean.

Item

http://www.wikidata.org/entity/Q53922357

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Mobilization policy in multipl ...... o sides of the Atlantic Ocean.

@en

Mobilization policy in multipl ...... o sides of the Atlantic Ocean.

@nl

type

Item

label

Mobilization policy in multipl ...... o sides of the Atlantic Ocean.

@en

Mobilization policy in multipl ...... o sides of the Atlantic Ocean.

@nl

prefLabel

Mobilization policy in multipl ...... o sides of the Atlantic Ocean.

@en

Mobilization policy in multipl ...... o sides of the Atlantic Ocean.

@nl

P1476

Mobilization policy in multipl ...... o sides of the Atlantic Ocean.

@en

P2093

A Olivieri

http://www.w3.org/2001/XMLSchema#string

F Saraceni

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-l

Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.

Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.

Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system.

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.

Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial

Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma.

Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations.

Mobilized peripheral blood grafts include more than hematopoietic stem cells: the immunological perspective.

P2888

bmt.2015.317

P304

348-350

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2015.317

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1021922296

http://www.w3.org/2001/XMLSchema#string

P698

26691418

http://www.w3.org/2001/XMLSchema#string

Mobilization policy in multiple myeloma: minimum target or law of redundancy? Two different approaches by the two sides of the Atlantic Ocean.

about

P2860

P2860

Mobilization policy in multiple myeloma: minimum target or law of redundancy? Two different approaches by the two sides of the Atlantic Ocean.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698